If generalizable AI models are to meaningfully contribute to precision cancer care, they’ll need to incorporate not only imaging data but also digitalized clinical notes, biomarker assays and monitor readouts.

Could wearables help AFib patients take fewer blood-thinning medications and reduce their risk of stroke? The team behind a new seven-year analysis hopes to find out. 

Compared to USPSTF 2013,  modified eligibility criteria could increase cancer detection by 37%.

According to the agency, directories can serve as important resources for patients who need to locate providers or compare health plan networks.

Recently a radiomics-based machine learning model proved highly accurate at predicting which patients would develop pancreatic cancer three to 36 months after abdominal CT imaging.

Should patients read their radiology reports ahead of the doctor who ordered the exam? That’s not a new question. It was supposed to have been settled in the affirmative by the 21st Century Cures Act.

A Big Four tech company has launched a platform it hopes will accelerate data interoperability and AI adoption in, specifically, medical imaging.

We spoke to executives from some of healthcare's most prominent vendors to find out what challenges are on their radar in 2022 and beyond.